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Pública e Forenses e Educação Médica, Faculdade de Medicina da Universidade do Porto, Porto, Portugal,
23 Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa,
24 Institute of Medicine, Tribuvan, University Kathmandu, Nepal, 25 Faculty of Agricultural and Food
Sciences, American University of Beirut, Beirut, Lebanon, 26 Laboratory of Epidemiology of Chronic and
Neurological Diseases, Faculty of Health Sciences, University of Abomey–Calavi, Cotonou, Benin,
27 Department of Epidemiology and Biostatistics, School of Public Health, Makerere University, Kampala,
Uganda, 28 Health Research and Epidemiology Unit, Ministry of Health, Thimphu, Bhutan, 29 University
Center of Primary Care and Health Services (Unisanté), Lausanne, Switzerland, 30 Ministry of Health,
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Cardiovascular diseases are leading causes of death, globally, and health systems that
deliver quality clinical care are needed to manage an increasing number of people with risk
factors for these diseases. Indicators of preparedness of countries to manage cardiovascu-
lar disease risk factors (CVDRFs) are regularly collected by ministries of health and global
health agencies. We aimed to assess whether these indicators are associated with patient
receipt of quality clinical care.
Methods and findings
We did a secondary analysis of cross-sectional, nationally representative, individual-patient
data from 187,552 people with hypertension (mean age 48.1 years, 53.5% female) living in
43 low- and middle-income countries (LMICs) and 40,795 people with diabetes (mean age
52.2 years, 57.7% female) living in 28 LMICs on progress through cascades of care (condi-
tion diagnosed, treated, or controlled) for diabetes or hypertension, to indicate outcomes of
provision of quality clinical care.
Data were extracted from national-level World Health Organization (WHO) Stepwise
Approach to Surveillance (STEPS), or other similar household surveys, conducted between
July 2005 and November 2016. We used mixed-effects logistic regression to estimate asso-
ciations between each quality clinical care outcome and indicators of country development
(gross domestic product [GDP] per capita or Human Development Index [HDI]); national
capacity for the prevention and control of noncommunicable diseases (‘NCD readiness indi-
cators’ from surveys done by WHO); health system finance (domestic government expendi-
ture on health [as percentage of GDP], private, and out-of-pocket expenditure on health
[both as percentage of current]); and health service readiness (number of physicians,
nurses, or hospital beds per 1,000 people) and performance (neonatal mortality rate). All
models were adjusted for individual-level predictors including age, sex, and education. In an
exploratory analysis, we tested whether national-level data on facility preparedness for dia-
betes were positively associated with outcomes. Associations were inconsistent between
indicators and quality clinical care outcomes. For hypertension, GDP and HDI were both
positively associated with each outcome. Of the 33 relationships tested between NCD readi-
ness indicators and outcomes, only two showed a significant positive association: presence
of guidelines with being diagnosed (odds ratio [OR], 1.86 [95% CI 1.08–3.21], p = 0.03) and
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availability of funding with being controlled (OR, 2.26 [95% CI 1.09–4.69], p = 0.03). Hospital
beds (OR, 1.14 [95% CI 1.02–1.27], p = 0.02), nurses/midwives (OR, 1.24 [95% CI 1.06–
1.44], p = 0.006), and physicians (OR, 1.21 [95% CI 1.11–1.32], p < 0.001) per 1,000 people
were positively associated with being diagnosed and, similarly, with being treated; and the
number of physicians was additionally associated with being controlled (OR, 1.12 [95% CI
1.01–1.23], p = 0.03). For diabetes, no positive associations were seen between NCD readi-
ness indicators and outcomes. There was no association between country development,
health service finance, or health service performance and readiness indicators and any out-
come, apart from GDP (OR, 1.70 [95% CI 1.12–2.59], p = 0.01), HDI (OR, 1.21 [95% CI
1.01–1.44], p = 0.04), and number of physicians per 1,000 people (OR, 1.28 [95% CI 1.09–
1.51], p = 0.003), which were associated with being diagnosed. Six countries had data on
cascades of care and nationwide-level data on facility preparedness. Of the 27 associations
tested between facility preparedness indicators and outcomes, the only association that
was significant was having metformin available, which was positively associated with treat-
ment (OR, 1.35 [95% CI 1.01–1.81], p = 0.04). The main limitation was use of blood pres-
sure measurement on a single occasion to diagnose hypertension and a single blood
glucose measurement to diagnose diabetes.
Conclusion
In this study, we observed that indicators of country preparedness to deal with CVDRFs are
poor proxies for quality clinical care received by patients for hypertension and diabetes. The
major implication is that assessments of countries’ preparedness to manage CVDRFs
should not rely on proxies; rather, it should involve direct assessment of quality clinical care.
Author summary
Why was the study done?
• Diseases such as high blood pressure and diabetes are becoming increasingly common
in low- and middle-income countries (LMICs).
• Treatment for these conditions is simple and cheap. However, without treatment, suf-
ferers are at high risk of adverse consequences, such as heart attacks and strokes.
• It is important therefore to be able to measure whether patients who need treatment are
getting it. Currently, LMICs’ progress towards being able to treat patients with hyper-
tension and diabetes is measured using proxies, for example, whether policies, guide-
lines, funding, structures, or human resources are in place.
What did the researchers find?
• We measured whether 187,552 people with hypertension living in 43 LMICs and 40,795
people with diabetes living in 28 LMICs had their high blood pressure or diabetes
treated well; i.e., they had these conditions diagnosed, treated, or controlled.
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• We found that most proxy measures were not reflective of whether patients had their
condition treated well.
What do these findings mean?
• To judge countries’ progress towards ability to treat hypertension and diabetes requires
directly assessing whether people with these diseases are getting the treatment that they
need.
• The main limitation of the study was that a one-time measurement of blood pressure or
blood glucose was used to define whether participants had high blood pressure or diabe-
tes. To make a concrete clinical diagnosis requires more detailed investigation.
Introduction
Cardiovascular diseases are one of the most common causes of death and disability in low-
and middle-income countries (LMICs). Reducing premature mortality from these conditions
is a key aim of the Sustainable Development Goals (SDG 3.4) [1]. To ensure that this goal is
met requires identifying and adequately treating people who have conditions like diabetes and
hypertension. Monitoring country progress towards meeting this goal is essential to ensuring
commensurate investment in health systems to manage these conditions.
Globally, hundreds of indicators are collected or collated by governments, the World
Health Organization (WHO), World Bank, United States Agency for International Develop-
ment (USAID), and other multilateral and bilateral governmental and nongovernmental orga-
nisations, in order to evaluate healthcare capacity and performance. These indicators allow
assessment of temporal trends, comparisons between and within countries, identification of
aspects of healthcare requiring targeted investment and improvement, and signal areas in need
of further research. Different organisations often request distinct indicators and have numer-
ous and varying reporting requirements. This results in a substantial burden of collecting and
reporting on healthcare providers and managers, potentially detracting time and resources
from the delivery of quality clinical care to patients [2,3]. There have been efforts to rationalise
the number of indicators collected, for example, with the list of 100 Core Global Health Indica-
tors first being produced in 2015 [4]. However, thus far, adoption of such rationalised lists by
the global health and donor community has been slow. Also, many of these indicators are
proxies for patient outcomes that are based on conceptual frameworks, such as the Primary
Healthcare Performance Initiative’s Conceptual Framework of critical elements of a strong pri-
mary healthcare system [5]. These are often based upon the Donabedian ‘structures’ and ‘pro-
cesses’ needed to deliver care. Although these outcomes may be relatively easy to measure, the
utility of some of them to reflect quality clinical care outcomes (the Donabedian ‘outcomes’)
has been called into question, especially as many are based largely on expert opinion or feasi-
bility of collection [2,6,7]. Although for some indicators, clinical outcomes are clear (for exam-
ple, maternal mortality rate), for others, the relevance to outcomes may be remote, even if the
links between metric and outcome seem superficially clear (for example, the presence of a pol-
icy or plan).
There are several indicators used to measure countries’ preparedness for reducing the bur-
den of noncommunicable diseases (NCDs)—including cardiovascular diseases and their risk
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factors (cardiovascular disease risk factors [CVDRFs])—but few that are routinely collected
measure whether patient outcomes indicative of quality clinical care are achieved (for example,
disease diagnosis, treatment, or control). Prominent indicators recommended to reflect prog-
ress to achievement of NCD control include those collected by WHO in the National Capacity
for the Prevention and Control of Noncommunicable Diseases surveys (hereafter termed
‘NCD readiness’ indicators) [8]. Additionally, there are other indicators collected by global
agencies that could affect achievement of relevant patient clinical care outcomes. These range
from high-level indicators reflecting health service readiness (for example, number of service
providers available in any particular country) or those that have been used to reflect overall
health service performance (for example, neonatal mortality rate [NMR]), to health facility
readiness measures (for example, Service Availability and Readiness Assessment [SARA] and
Service Provision Assessment [SPA]) [9,10]. In addition to regularly collected indicators, indi-
vidual patient–level factors (e.g., demographic and socioeconomic characteristics) and mark-
ers of overall country development (e.g., gross domestic product [GDP]) are also known to
impact on achievement of patient clinical care outcomes [11–14].
For the CVDRFs of hypertension and diabetes, disease burden has been estimated using
modelling [15], and previous studies have associated limited health service performance or
readiness measures with modelled prevalence [14]. However, author knowledge and review of
the literature showed that achievement of quality clinical care to manage prevalent disease
across multiple countries has not previously been associated with indicators commonly used
to assess performance of the health services or NCD readiness indicators. Empiric individual-
patient data for hypertension and diabetes [11–13,16] are regularly collected using the WHO
Stepwise Approach to Surveillance (WHO STEPS) [17,18] and similar surveys. We have
recently used individual participant data from these surveys to create cascades of care which
assess whether individuals identified as having hypertension or diabetes have been diagnosed,
treated, or are controlled to target [11,12].
In order to inform the evidence-based collection and use of country preparedness indica-
tors for CVDRFs, we aimed to assess whether the NCD readiness indicators are proxies of, and
thus associated with, patient-level quality clinical care outcomes as determined by progress
through cascades of care (to assess whether conditions are diagnosed, treated [both proximate
to patient ‘process’ measures], or controlled [an ‘outcome measure’] for individual patients).
We also aimed to assess whether or not these indicators are stronger predictors of achieving
success along the cascade of care than other indicators likely to effect health service provision
of care for CVDRFs.
Methods
This study is reported as per the Strengthening the Reporting of Observational Studies in Epi-
demiology (STROBE) guideline (S1 Checklist). None of the analyses presented in this paper
were prespecified in a protocol. The decisions to exclude the indicators, (1) operational multi-
sectoral national policy for NCDs and shared risk factors and (2) NCD surveillance and moni-
toring system in place to enable reporting against the nine global NCD targets, and to evaluate
the correlation of country wealth and health expenditure were made during data analysis.
Indicator measures
We conceptualised a high-level working framework based upon the author’s knowledge of
health systems (in particular, informed by Atun’s 2013 framework for analysis of Turkey’s
health system [19]), available rigorously collected data, and CVDRF care. We then collated
numerous variables collected by health and development agencies and mapped to this
PLOS MEDICINE Association between preparedness indicators and provision of care for CVD risk factors LMICs
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framework those that authors agreed were most relevant. Where there were multiple variables
within these data sources of potential relevance to the study question, those selected were cho-
sen (on discussion between JID, SKR, LMJ, LRH, PG, and JMG) based on relevance to the
question, avoidance of duplication, and availability within 2 years of the data used to construct
the care cascade. Given that care delivery for CVDRFs has not changed rapidly in many
LMICs, it was decided that the 2-year threshold allowed reasonable temporal comparability
between data sources.
Our framework was hierarchical. We started with the country context in which the health
system sits, hypothesising that a strong health system to enable care for complex chronic con-
ditions, like CVDRFs, would be more likely in countries with a higher Human Development
Index (HDI) or those with a higher GDP (markers of country development). In this hierarchi-
cal framework, markers of NCD readiness are high-level factors as they reflect countries’ com-
mitment to facilitate quality clinical outcomes for CVDRF. At the next level were high-level
factors focussed on financial spending on health and equity (indicators of health service
finance and equity). More proximate to the patient are indicators of health service perfor-
mance (whether a health service is delivering care) or readiness (whether it is able to deliver
care). Health facility readiness indicators reflect facility readiness to provide specific care for
CVDRFs. Lastly are the patient-proximate indicators of individual-level patient characteristics.
Categorisation of variables, sources from which these have been extracted, and number of
countries for which information on each variable was available are summarised in Table 1
(and S1–S4 Texts and S1 Table).
GDP per capita (current $US) and HDI were selected as measures of overall country devel-
opment. For NCD readiness indicators, we selected responses to NCD-specific health service
policies of relevance for management of CVDRFs. General health service finance and equity
markers were chosen to reflect country healthcare expenditure (current health expenditure as
a percentage of total GDP) and the equity of funding for health (domestic private health expen-
diture as percentage of current health expenditure or out-of-pocket [OOP] expenditure as per-
centage of current health expenditure). Other health service performance or readiness
indicators were chosen because they had either been previously shown to be associated with
prevalent NCDs (hospital beds or human resources for health) or were targets of the Millen-
nium Development Goals (MDGs), which may reflect performance of the health service, rather
than siloed care (i.e., NMR was chosen over maternal mortality ratio [MMR] because improv-
ing NMR requires that care is provided to both the mother and neonate) [14,20]. Health facil-
ity readiness indicators to give additional granular information on care specific to diabetes
were available for a subset of countries (n = 6); we considered the use of these in our analysis
as exploratory.
HDI was extracted from the UN Human Development Reports [21]. GDP per capita (cur-
rent $US); current health expenditure (as percentage of GDP); domestic private health expen-
diture (as percentage of current health expenditure); OOP expenditure (as percentage of
current health expenditure); hospital beds, nurses and midwives, and physicians per 1,000 peo-
ple; and NMR per 1,000 live births were extracted from the World Development Indicators
[22]. Indicators were extracted from these sources for the year corresponding to the start of
the survey from which cascades were derived (and within 2 years when data from the same
year were not available). Note, for OOP expenditure, ‘of current’ is how the metric is reported
by the source; for each country, data were extracted for the year in which the cascade survey
was done; thus, ‘current’ refers to that year.
NCD readiness indicators were extracted from WHO National Capacity for the Prevention
and Control of Noncommunicable Diseases surveys [8]. These were categorised as ‘yes’, posi-
tive response; ‘no’ (referent category), negative report, do not know, or question asked but no
PLOS MEDICINE Association between preparedness indicators and provision of care for CVD risk factors LMICs
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Table 1. Summary of independent variables included in analysis.
Level of Analysis Variable Data Source� Number of Countries With
Available Data out of 44 Countries
Included
Country development GDP per capita (current $US) WDI [22] 44
Human Development Index† UNDP [21] 41
NCD readiness
indicators
Has an operational NCD unit/branch or department within the
Ministry of Health, or equivalent
WHO National Capacity
for NCDs Report [8]
39
Has evidence-based national guidelines/protocols/standards for the




Has an operational multisectoral national policy, strategy, or action




Funding available for NCD surveillance, monitoring, and evaluation





NCD surveillance and monitoring service in place to enable reporting




Has an integrated or topic-specific policy, programme, or action plan




Has an integrated or topic-specific policy, programme, or action plan




Has an operational policy, strategy, or action plan to reduce physical




Has an operational policy, strategy, or action plan to reduce unhealthy




Has an operational policy, strategy, or action plan to reduce the




Has an operational policy, strategy, or action plan to reduce the






Current health expenditure (percentage of GDP) WDI 44
Domestic private health expenditure (percentage of current health
expenditure)
WDI 44




NMR (per 1,000 live births) WDI 44
Hospital beds (per 1,000 people) WDI 29
Nurses and midwives (per 1,000 people) WDI 36
Physicians (per 1,000 people) WDI 35
Health facility readiness
for diabetes
Percent of facilities with insulin SARA/SPA [9,10] 6
Percent of facilities with metformin SARA/SPA 6
Percent of facilities with glibenclamide SARA/SPA 5
Percent of facilities offering diabetes diagnostic and management
services
SARA/SPA 4
Among facilities offering diabetes diagnosis and management services,
percent with at least one trained staff in diabetes diagnostic and
management
SARA/SPA 4
Among facilities offering diabetes diagnosis and management services,
percent with guidelines for diagnosis and management
SARA/SPA 4
Among facilities offering diabetes diagnosis and management services,
percent with blood pressure apparatus
SARA/SPA 4
Among facilities offering diabetes diagnosis and management services,
percent with blood glucose measurement capacity
SARA/SPA 4
Among facilities offering diabetes diagnosis and management services,
percent with adult weighing scale
SARA/SPA 4
(Continued)
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response; and ‘country did not respond to survey’. Countries with no survey available within 2
years or in which the question was not asked on the survey were set to missing.
Granular health facility readiness data pertaining to diabetes (and reflecting availability of
structures—for example, guidelines, equipment, staff, etc—necessary to provide care at facili-
ties) were extracted from national summaries of reports from WHO SARA and, if SARA sur-
veys were not available, from SPA surveys. These data were extracted from reports from
within 2 years of the survey from which cascades were derived being done. For countries with
both survey types available, we chose SARA rather than SPA, given that the majority of surveys
used were SARA.
Finally, individual-level patient characteristics (age, sex, and education) were extracted
from surveys from which the quality clinical care outcomes were derived [11,12].
Patient-level quality clinical care outcome measures
Using individual-patient data from rigorously conducted nationally representative surveys, we
evaluated three care-cascade outcomes which reflect quality clinical care provision for the
CVDRFs of hypertension and diabetes, thus making six clinical care variables in total. These
were (1) knowledge of condition (‘diagnosed’), (2) knowledge of condition and being on treat-
ment (‘treatment’), and (3) on treatment and condition controlled to target (‘controlled’). We
conducted separate analyses for hypertension and diabetes. Methods for deriving progress
through the care cascade for hypertension and diabetes have been described in full elsewhere
[11,12].
In short, for hypertension, we pooled nationally representative, individual-level population-
based data collected between July 2005 and November 2016 from 43 LMICs. Half of the sur-
veys (n = 21) were WHO STEPS surveys, and the remaining 22 were Demographic and Health
Surveys (DHS), Family Life Surveys, WHO Study on global AGEing and adult health (SAGE)
surveys, or other national health surveys. Hypertension was defined as systolic blood pressure
(BP)�140 mm Hg or diastolic BP�90 mm Hg or reporting use of medication for hyperten-
sion. We computed the percentage of all those with hypertension who had previously been
diagnosed with hypertension by a healthcare provider (‘diagnosed’); those with hypertension
who had been diagnosed and were taking antihypertensive medications (‘treated’); and those
with hypertension who had been diagnosed, had been treated, and had a systolic BP<140 mm
Hg and a diastolic BP <90 mm Hg (‘controlled’).
Table 1. (Continued)
Level of Analysis Variable Data Source� Number of Countries With













�WDI data downloaded between 23 and 25 September 2018 and the Human Development Index extracted on 30 December 2018.
†Human Development Index is a composite of GNI per capita, education variables, and life expectancy.
Abbreviations: GDP, gross domestic product; GNI, gross national income; NCD, noncommunicable disease; NMR, neonatal mortality rate; SARA, Service Availability
and Readiness Assessment; SPA, Service Provision Assessment; UNDP, United Nations Development Program; WDI, World Development Indicators; WHO, World
Health Organization.
https://doi.org/10.1371/journal.pmed.1003268.t001
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For diabetes, we pooled nationally representative, individual-level population-based data col-
lected between August 2008 and November 2016 in 28 LMICs. Diabetes was defined as fasting
plasma glucose�7.0 mmol/l (126 mg/dl), random plasma glucose�11.1 mmol/l (200 mg/dl),
HbA1c�6.5%, or reporting taking medication for diabetes. Eighteen of the surveys were WHO
STEPS surveys, and the remaining 10 were from DHS, Family Life Surveys, or other national
health surveys. Analogous to the hypertension cascade, we computed the percentage of all those
with diabetes who had previously been diagnosed with diabetes by a healthcare provider (‘diag-
nosed’); those with diabetes who had been diagnosed and were taking antidiabetic medications
(‘treated’); and those with diabetes who had been diagnosed, had been treated, and had a plasma
glucose<10.1 mmol/l or, if available (n = 4 surveys), HbA1c<8.0% (‘controlled’).
Ethics
This study received a written determination of ‘not human subjects research’ by the institu-
tional review board of the Harvard T.H. Chan School of Public Health on 9 May 2018 (IRB16-
1915). The investigators on this study had only access to deidentified data and never had any
direct contact with any of the participants in the individual country studies that provided the
data.
Statistical analysis
Our aim was to assess if NCD readiness or other health service performance or readiness indi-
cators were useful proxies for quality clinical care and to describe whether they were stronger
indicators of quality clinical care than general country development or health system finance
and equity indicators. We did not aim to assess causation. We first summarised the country-
level indicators for the 44 countries included in this sample using descriptive statistics. To
determine the association of indicators with each of the six clinical care outcomes (condition
diagnosed, treated, or controlled for both diabetes and hypertension), we used maximum like-
lihood estimation of mixed-effects logistic regression models with a binary outcome (indicat-
ing whether or not the individual achieved the clinical care outcome) and robust variance
estimation (S5 Text). The sample for each regression was all individuals with diabetes or, for
the three clinical care outcomes specific to hypertension, all individuals with hypertension. All
models were adjusted for country, specified as a random effect, and individual-level predictors,
specified as fixed effects (age, sex, and education). These individual-level predictors have previ-
ously been shown to be predictive of progress through the cascades of care [11,12]. Because
only two countries with the hypertension-related outcomes and one country with the diabetes-
related outcomes answered ‘yes’ to (1) operational multisectoral national policy for NCDs and
shared risk factors and (2) NCD surveillance and monitoring system in place to enable report-
ing against the nine global NCD targets, we excluded these two indicators from the analyses
for that outcome. Continuous indicators (GDP per capita [current $US], HDI, current health
expenditure [percentage of GDP], domestic private health expenditure [percentage of current
health expenditure], OOP expenditure [percentage of current health expenditure], NMR [per
1,000 live births], hospital beds [per 1,000 people], nurses and midwives [per 1,000 people],
and physicians [per 1,000 people]) were rescaled to have a mean of zero and a standard devia-
tion (SD) of one to ease interpretation and comparisons across variables. Regression analyses
took into account sample weights, which were rescaled by dividing an individual’s sample
weight by the sum of weights of respondents in the estimation sample such that all sample
weights within the sample summed to 1 and thus all countries contributed equally to the over-
all estimates. All analyses were done in Stata v. 14.2 (StataCorp, College Station, TX, USA).
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Results
A total of 44 countries with data available from between 2005 and 2016 were included in the
analysis; 43 countries had data on cascade steps for hypertension and country preparedness
metrics and 28 countries had data available for diabetes (1 country had data on diabetes, but
not hypertension). Table 1 (and S1 Table) shows the availability of each metric. Country-level
indicators assessed in this analysis are summarised in Table 2. Individual-level characteristics
of participants are summarised in Table 3.
Of note, GDP per capita and HDI were low (mean ± SD GDP per capita of $US 4,335 ±
$US 3,681 and HDI 0.65 ± 0.12), reflecting the LMIC status of the countries included. Infor-
mation on NCD readiness indicators of relevance to CVDRFs were available from 39 countries
(Table 1). Table 4 shows individual countries who responded positively (‘yes’) to survey ques-
tions on NCD readiness. Two-thirds of countries (66.7%) had an operational NCD unit/
branch/department in their Ministry of Health, or equivalent, and 74.4% had at least one oper-
ational policy for CVD, diabetes, physical activity, healthy diets, tobacco, or alcohol. The most
common operational policy was for tobacco control, whereas the least common was for alco-
hol. About two-thirds of countries (65.0%) had some funding for surveillance, prevention, or
treatment. Current health expenditure was a mean ± SD of 5.9% ± 2.0% of GDP; private health
expenditure was 43.2% ± 19.0% of current, and OOP expenditure was 37.0% ± 18.9% of
current.
Progress through cascades of care for both hypertension and diabetes are shown in Table 3:
40.7% (95% CI 37.9%–43.5%) were diagnosed, 27.6% (95% CI 25.7%–29.7%) had received
treatment, and 11.1% (95% CI 10.2%–12.0%) were controlled. Corresponding figures for dia-
betes were 43.4% (95% CI 39.5%–47.5%) diagnosed, 34.7% (95% CI 32.2%–37.3%) treated,
and 21.1% (95% CI 19.6%–22.5%) controlled.
Association between indicators and hypertension care
Individuals with hypertension living in countries with a higher GDP per capita or higher HDI
were significantly more likely to be diagnosed, treated, and achieve control (Table 5); GDP per
capita was the strongest predictor of hypertension care including diagnosis (odds ratio [OR],
1.58 [95% CI 1.27–1.96], p< 0.001), treatment (OR, 1.49 [95% CI 1.15–1.93], p = 0.002), and
control (OR, 1.57 [95% CI 1.22–2.02], p = 0.001).
In general, NCD readiness indicators were not associated with achieving cascade steps.
However, individuals with hypertension living in countries with evidence-based national
guidelines/protocols/standards for the management of major NCDs through a primary care
approach were significantly more likely to have been diagnosed (OR, 1.86 [95% CI 1.08–3.21],
p = 0.03). Having funding for NCD surveillance, monitoring, and evaluation; treatment and
control; and/or prevention and health promotion was significantly and strongly associated
with achieving hypertension control (OR, 2.26 [95% CI 1.09–4.69], p = 0.03). The association
between having funding available for NCD surveillance, monitoring, and evaluation; treatment
and control; and/or prevention and health promotion and being treated for hypertension did
not achieve significance (OR, 1.41 [95% CI 0.83–2.41], p = 0.21).
The indicators reflecting health service finances (current health expenditure, private health
expenditure, or OOP expenditures) were not significant predictors of any of the stages of the
hypertension care cascade. But general health service performance or readiness indicators did
reflect achievement of some cascade steps. Individuals living in countries with lower NMRs
were more likely to be diagnosed (OR, 0.73 [95% CI 0.61–0.88], p = 0.001). Those with a
greater number of hospital beds, nurses and midwives, and physicians were more likely to be
diagnosed and treated (all p< 0.05; OR and 95% CI presented in Table 5). These variables
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Table 2. Summary of country-level indicators assessed in this analysis, presented for countries for which hypertension or diabetes outcomes were available to study.
Indicator Countries with Hypertension
Outcomes
(n = 43), Presented as Mean
(SD) or % (n)
Countries with Diabetes
Outcomes
(n = 28), Presented as Mean
(SD) or % (n)
Country development
GDP per capita (current $US) 4,357 ± 3,722 3,886 ± 3,615
Human Development Index 0.64 ± 0.12 0.62 ± 0.12
NCD readiness
Operational NCD unit/branch/department in Ministry of Health
Yes 65.8 (25) 73.1 (19)
No 21.1 (8) 11.5 (3)
No response 13.2 (5) 15.4 (4)
National guidelines for NCD management with primary care approach
Yes 33.3 (8) 25.0 (4)
No 45.8 (11) 50.0 (8)
No response 20.8 (5) 25.0 (4)
Operational multisectoral national policy for NCDs and shared risk factors
Yes 8.3 (2) 6.3 (1)
No 70.8 (17) 68.8 (11)
No response 20.8 (5) 25.0 (4)
Funding available for NCD surveillance, monitoring, and evaluation; treatment and
control; and/or prevention and health promotion
Yes 63.2 (12) 57.1 (8)
No 10.5 (2) 14.3 (2)
No response 26.3 (5) 28.6 (4)
NCD surveillance and monitoring service
Yes 8.3 (2) 6.3 (1)
No 70.8 (17) 68.8 (11)
No response 20.8 (5) 25.0 (4)
Integrated or topic-specific policy currently operational for CVDs
Yes 31.6 (6) 35.7 (5)
No 42.1 (8) 35.7 (5)
No response 26.3 (5) 28.6 (4)
Integrated or topic-specific policy operational for diabetes
Yes 31.6 (6) 35.7 (5)
No 42.1 (8) 35.7 (5)
No response 26.3 (5) 28.6 (4)
Operational policy to promote physical activity
Yes 36.8 (14) 34.6 (9)
No 50.0 (19) 50.0 (13)
No response 13.2 (5) 15.4 (4)
Operational policy to promote healthy diets
Yes 44.7 (17) 42.3 (11)
No 42.1 (16) 42.3 (11)
No response 13.2 (5) 15.4 (4)
Operational policy to reduce tobacco
Yes 50.0 (19) 50.0 (13)
No 36.8 (14) 34.6 (9)
No response 13.2 (5) 15.4 (4)
(Continued)
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were less predictive of control, with only the number of physicians being a significant predictor
of hypertension control in this sample (OR, 1.12 [95% CI 1.01–1.23], p = 0.03).
Association between indicators and diabetes care
In contrast to what was seen for hypertension care, GDP per capita and HDI were not consis-
tently strong predictors of the stages of the diabetes cascade of care (Table 6); although they
were both significantly associated with being diagnosed with diabetes (for GDP per capita,
OR, 1.70 [95% CI 1.12–2.59], p = 0.01; and for HDI, OR, 1.21 [95% CI 1.01–1.44], p = 0.04).
Two results ran counter to our hypothesis; individuals with diabetes living in countries
with an operational NCD unit/branch/department in Ministry of Health were significantly less
likely to have been diagnosed (OR, 0.36 [95% CI 0.18–0.72], p = 0.004), and those living in
countries that reported having evidence-based national guidelines/protocols/standards for the
management of major NCDs through a primary care approach were significantly less likely to
Table 2. (Continued)
Indicator Countries with Hypertension
Outcomes
(n = 43), Presented as Mean
(SD) or % (n)
Countries with Diabetes
Outcomes
(n = 28), Presented as Mean
(SD) or % (n)
Operational policy to reduce the harmful use of alcohol
Yes 31.6 (12) 34.6 (9)
No 55.3 (21) 50.0 (13)
No response 13.2 (5) 15.4 (4)
Health service finance
Current health expenditure (percentage of GDP) 6.0 ± 2.0 5.7 ± 2.2
Private health expenditure (percentage current health expenditure) 43.5 ± 19.1 41.8 ± 19.4
Out-of-pocket expenditure (percentage of current health expenditure) 37.3 ± 19.0 35.1 ± 19.5
Health service performance and readiness
NMR (per 1,000 live births) 17.3 ± 10.1 18.3 ± 9.1
Hospital beds (per 1,000 people) 3.0 ± 2.7 2.1 ± 1.8
Nurses and midwives (per 1,000 people) 2.9 ± 2.8 2.0 ± 1.8
Physicians (per 1,000 people) 1.3 ± 1.4 0.9 ± 1.2
Facility-level readiness�
Have insulin 26.2 ± 26.5
Have metformin 38.4 ± 29.7
Have glibenclamide 37.3 ± 34.1
Offer diabetes diagnostic and management services 28.5 ± 15.0
Among those who offer diabetes diagnostic and management services
Have trained staff in diabetes diagnostic and management 19.7 ± 14.0
Have guidelines for diagnosis and management 24.5 ± 14.8
Have blood pressure apparatus 95.6 ± 3.0
Have blood glucose measurement capacity 25.2 ± 17.7
Have adult weighing scale 90.7 ± 5.8
All countries contributed equally to these estimates.
For health service policy, NCD specific, ‘yes’ indicates a positive response to the question; ‘no’ indicates a negative response to the question, do not know, or question
asked but no response; and ‘no response’ indicates country did not respond to survey.
�All values are percent of facilities nationally.
Abbreviations: CVD, cardiovascular disease; NCD, noncommunicable disease; NMR, neonatal mortality rate; SD, standard deviation
https://doi.org/10.1371/journal.pmed.1003268.t002
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have been treated (OR, 0.34 [95% CI 0.24–0.47], p< 0.001). However, none of the other pre-
dictors were significant for any stage of the diabetes cascade. The four countries that
responded that they had guidelines were Bhutan, Indonesia, Romania, and Seychelles, whereas
the countries that performed highest in achieving the cascade steps, such as Costa Rica, did not
report having such guidelines (Table 4). Of the health service performance or readiness indica-
tors, only the number of physicians per 1,000 people was associated with diabetes diagnosis
(OR, 1.28 [95% CI 1.09–1.51], p = 0.003).
Not responding to the NCD-specific policy questionnaires was not associated with worse
performance in achieving any step of the diabetes or hypertension cascade.
In the exploratory analysis considering facility readiness, data were available for six coun-
tries: Burkina Faso, Kenya, Nepal, Togo, Tanzania, and Uganda. Tanzania had data from both
Table 3. Summary of individual-level data used in this analysis. The hypertension sample includes data from 43







Age (years) 48.1 (47.4–48.7) 52.2 (51.4–53.1)
Sex
Male 46.5 (45.5–47.6)











No formal schooling 19.4 (17.8–21.2)




Primary school 31.3 (29.3–33.4)




Secondary school or above 49.3 (47.5–51.1)





Diagnosis of hypertension among hypertensives (percent yes) 40.7 (37.9–43.5)
unweighted n = 68,458
Treatment of hypertension among hypertensives diagnosed
(percent yes)
27.6 (25.7–29.7)
unweighted n = 48,735
Control of hypertension among hypertensives diagnosed and
treated (percent yes)
11.1 (10.2–12.0)
unweighted n = 23,599
Diagnosis of diabetes among diabetics (percent yes) 43.4 (39.5–47.5)
unweighted
n = 12,931
Treatment of diabetes among diabetics diagnosed (percent yes) 34.7 (32.2–37.3)
unweighted
n = 11,932





Values are weighted mean (95% CI) or weighted percent (95% CI) and unweighted n. All countries contributed
equally to estimates.
https://doi.org/10.1371/journal.pmed.1003268.t003
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Countries shaded in light orange were included in diabetes cascades. All countries except Fiji (for which blood pressure data were not available) were included in the
hypertension cascades. Responses to questions are shaded as follows: white, ‘no’; orange, ‘yes’; grey, ‘no response to survey’; blue, ‘responded to survey, but question not
asked in survey’. N = 5 countries (Azerbaijan, Georgia, Guyana, Mozambique, and Ukraine) were missing data and are not listed in table.
Abbreviations: CVD, cardiovascular disease; NCD, noncommunicable disease
https://doi.org/10.1371/journal.pmed.1003268.t004
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GDP per capita (per SD) 1.58 (1.27–1.96) 1.49 (1.15–1.93) 1.57 (1.22–2.02)
Human Development Index (per SD) 1.26 (1.14–1.40) 1.19 (1.02–1.38) 1.23 (1.04–1.46)
NCD readiness
Operational NCD unit/branch/department in
Ministry of Health
Yes 0.83 (0.41–1.67) 1.78 (0.61–5.22) 1.42 (0.56–3.63)
No Ref. Ref. Ref.
No response 0.75 (0.31–1.83) 1.52 (0.47–4.88) 1.10 (0.42–2.93)
National guidelines for NCD management with
primary care approach
Yes 1.86 (1.08–3.21) 0.95 (0.36–2.45) 0.95 (0.39–2.27)
No Ref. Ref. Ref.
No response 1.05 (0.55–2.01) 0.97 (0.50–1.88) 0.80 (0.45–1.43)
Funding available for NCD surveillance,
monitoring, and evaluation; treatment and
control; and/or prevention and health promotion
Yes 1.17 (0.65–2.11) 1.41 (0.83–2.41) 2.26 (1.09–4.69)
No Ref. Ref. Ref.
No response 1.07 (0.55–2.06) 1.21 (0.69–2.12) 1.76 (1.07–2.91)
Integrated or topic-specific policy currently
operational for CVD
Yes 1.51 (0.76–3.00) 1.33 (0.65–2.74) 1.12 (0.38–3.31)
No Ref. Ref. Ref.
No response 1.12 (0.49–2.53) 1.01 (0.43–2.42) 0.88 (0.30–2.58)
Integrated or topic-specific policy operational
for diabetes
Yes 1.51 (0.76–3.00) 1.33 (0.65–2.74) 1.12 (0.38–3.31)
No Ref. Ref. Ref.
No response 1.12 (0.49–2.53) 1.01 (0.43–2.42) 0.88 (0.30–2.58)
Operational policy to promote physical activity
Yes 1.13 (0.69–1.83) 1.55 (0.85–2.83) 1.72 (0.90–3.28)
No Ref. Ref. Ref.
No response 0.92 (0.47–1.79) 1.17 (0.58–2.34) 1.09 (0.60–1.97)
Operational policy to promote healthy diets
Yes 1.33 (0.86–2.06) 1.13 (0.64–1.98) 1.32 (0.71–2.46)
No Ref. Ref. Ref.
No response 1.02 (0.54–1.94) 1.01 (0.52–1.96) 0.97 (0.54–1.74)
Operational policy to reduce tobacco
Yes 1.42 (0.88–2.30) 1.05 (0.57–1.95) 1.04 (0.50–2.17)
No Ref. Ref. Ref.
No response 1.08 (0.52–2.22) 0.97 (0.46–2.07) 0.84 (0.39–1.83)
Operational policy to reduce the harmful use of
alcohol
Yes 1.22 (0.75–1.97) 1.42 (0.76–2.63) 1.56 (0.77–3.14)
No Ref. Ref. Ref.
No response 0.94 (0.48–1.83) 1.08 (0.54–2.16) 0.99 (0.53–1.84)
Health service finance
(Continued)
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surveys and SARA was used; Nepal only had SPA data. There were no significant positive asso-
ciations between any indicators of health facility readiness and achieving diabetes care-cascade
steps, except having metformin available, which was positively associated with treatment (OR,
1.35 [95% CI 1.01–1.81], p = 0.04). Moreover, there were some indicators that were signifi-
cantly negatively associated with achieving cascade steps (Table 6); for example, offering dia-
betes diagnosis and management services was associated with a lower OR of being diagnosed
(OR, 0.56 [95% CI 0.39–0.82], p = 0.003) and treated (OR, 0.63 [95% CI 0.42–0.93], p = 0.02)
as compared to not offering these service.
Post hoc analyses done to explore relationships between country wealth and health expen-
diture showed GDP was significantly associated with OOP expenditure (Pearson correlation
coefficient, −0.34, p = 0.02) but not significantly associated with lower private healthcare
expenditure (Pearson correlation coefficient, −0.26, p = 0.09).
Discussion
We have found that few of the indicators widely collected as proxies of NCD or health service
preparedness assessed in this study were associated with progress through the CVDRF care
cascade. This was especially the case for people with diabetes, in whom some of the indicators
of NCD readiness and facility readiness to provide care were associated with significantly
worse achievement of our markers of quality clinical care. Although these findings are superfi-
cially unintuitive, they are likely reflective of the complexity of the health service elements and
their interactions that are required to deliver good-quality clinical care [23–26]. In fact, on
considering the multifaceted requirements to diagnose, manage, and control individuals with
chronic conditions such as diabetes and hypertension [27], it is unsurprising that these indica-
tors were not useful to assess good-quality clinical care outcomes.
Given their ease of assessment, NCD readiness and health service performance or readiness
indicators have been widely accepted proxies for quality clinical care, and, to our knowledge,
very little, if any, previous research has been done to compare country preparedness and qual-
ity clinical care outcomes for CVDRFs. However, evidence from the field of maternal and new-
born health is consistent with our overall finding that proxies are poor markers of the








Current health expenditure (per SD) 1.02 (0.87–1.20) 1.15 (0.93–1.43) 1.23 (0.95–1.60)
Private health expenditure (per SD) 0.92 (0.78–1.09) 1.05 (0.85–1.29) 1.03 (0.83–1.29)
Out-of-pocket expenditure (per SD) 0.95 (0.80–1.12) 1.04 (0.85–1.26) 1.01 (0.82–1.23)
Health service performance and readiness
NMR (per SD) 0.73 (0.61–0.88) 0.80 (0.63–1.00) 0.77 (0.58–1.02)
Hospital beds (per SD) 1.14 (1.02–1.27) 1.17 (1.02–1.33) 0.98 (0.83–1.15)
Nurses and midwives (per SD) 1.24 (1.06–1.44) 1.21 (1.00–1.48) 1.11 (0.88–1.40)
Physicians (per SD) 1.21 (1.11–1.32) 1.20 (1.10–1.30) 1.12 (1.01–1.23)
Values are OR (95% CI), adjusted for individual-level age, sex, and education and taking into account sample
weights, which were rescaled by the survey’s sample size such that all countries contributed equally to the overall
estimates.
Abbreviations: CVD, cardiovascular disease; GDP, gross domestic product; NCD, noncommunicable disease; NMR,
neonatal mortality rate; OR, odds ratio; Ref., reference
https://doi.org/10.1371/journal.pmed.1003268.t005
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GDP per capita (per SD) 1.70 (1.12–2.59) 1.36 (0.88–2.10) 1.29 (0.75–2.23)
Human Development Index (per SD) 1.21 (1.01–1.44) 1.09 (0.90–1.32) 1.01 (0.82–1.25)
NCD readiness
Operational NCD unit/branch/department in
Ministry of Health
Yes 0.36 (0.18–0.72) 1.80 (0.81–4.04) 0.97 (0.47–2.00)
No Ref. Ref. Ref.
No response 0.66 (0.23–1.90) 3.52 (1.20–10.36) 2.35 (0.83–6.65)
National guidelines for NCD management with
primary care approach
Yes 1.62 (0.51–5.14) 0.34 (0.24–0.47) 0.72 (0.35–1.49)
No Ref. Ref. Ref.
No response 1.60 (0.65–3.95) 1.56 (0.65–3.71) 2.22 (0.76–6.49)
Funding available for NCD surveillance,
monitoring, and evaluation; treatment and control;
and/or prevention and health promotion
Yes 1.79 (0.31–10.42) 1.75 (0.27–11.46) 1.16 (0.15–8.75)
No Ref. Ref. Ref.
No response 3.05 (0.46–20.46) 3.47 (0.50–24.30) 2.74 (0.41–18.53)
Integrated or topic-specific policy currently
operational for CVD
Yes 0.75 (0.24–2.31) 0.55 (0.17–1.78) 0.31 (0.08–1.27)
No Ref. Ref. Ref.
No response 1.52 (0.38–6.05) 1.44 (0.36–5.80) 1.17 (0.31–4.48)
Integrated or topic-specific policy operational for
diabetes
Yes 0.75 (0.24–2.31) 0.55 (0.17–1.78) 0.31 (0.08–1.27)
No Ref. Ref. Ref.
No response 1.52 (0.38–6.05) 1.44 (0.36–5.80) 1.17 (0.31–4.48)
Operational policy to promote physical activity
Yes 0.87 (0.41–1.85) 1.41 (0.68–2.92) 0.79 (0.33–1.90)
No Ref. Ref. Ref.
No response 1.50 (0.50–4.50) 2.62 (0.97–7.08) 2.07 (0.73–5.89)
Operational policy to promote healthy diets
Yes 1.24 (0.57–2.69) 1.06 (0.47–2.39) 0.71 (0.28–1.80)
No Ref. Ref. Ref.
No response 1.95 (0.64–5.90) 2.16 (0.73–6.38) 1.84 (0.59–5.73)
Operational policy to reduce tobacco
Yes 0.90 (0.35–2.35) 0.65 (0.24–1.72) 0.41 (0.15–1.11)
No Ref. Ref. Ref.
No response 1.52 (0.43–5.35) 1.48 (0.43–5.13) 1.26 (0.35–4.55)
Operational policy to reduce the harmful use of
alcohol
Yes 0.87 (0.41–1.85) 1.41 (0.68–2.92) 0.79 (0.33–1.90)
No Ref. Ref. Ref.
No response 1.50 (0.50–4.50) 2.62 (0.97–7.08) 2.07 (0.73–5.89)
Health service finance
(Continued)
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Although our results suggest that health service indicators should not be used in isolation to
indicate quality clinical care for management of diabetes or hypertension in LMICs and that
none of these indicators were very strong predictors of outcomes, even when significance was
achieved, some of our results are worthy of further exploration. We found that GDP per capita
was strongly associated with achieving all hypertension care-cascade steps. This is consistent
with long-standing evidence of the association between GDP and health [29]. This association
was initially thought to be driven by countries with higher GDP investing more in health, but
the bidirectionality of this association is also recognised, with healthier people more likely to
be able to contribute to their country’s economy. It is likely, in the countries under study, that
investing in health stems from a higher GDP. Indeed, our post hoc analysis of this sample of
countries showed a reasonably strong association between higher GDP and lower OOP expen-
ditures on health, although not with higher GDP and lower private healthcare expenditure.
These findings indicate that access to care might be more equitable in countries with a higher
GDP. Given the positive association between GDP and quality clinical care outcomes, it is not
surprising that countries’ HDI—which is reflective of economic wealth in addition to life








Current health expenditure (per SD) 1.07 (0.75–1.53) 1.13 (0.79–1.63) 1.19 (0.76–1.84)
Private health expenditure (per SD) 0.94 (0.72–1.23) 1.08 (0.82–1.43) 1.02 (0.70–1.47)
Out-of-pocket expenditure (per SD) 1.04 (0.81–1.33) 1.14 (0.89–1.47) 1.11 (0.77–1.60)
Health service performance and readiness
NMR (per SD) 0.85 (0.59–1.21) 0.99 (0.70–1.40) 1.12 (0.76–1.65)
Hospital beds (per SD) 1.30 (0.74–2.27) 1.31 (0.72–2.37) 1.50 (0.74–3.07)
Nurses and midwives (per SD) 1.44 (0.91–2.28) 0.94 (0.65–1.35) 0.94 (0.67–1.32)
Physicians (per SD) 1.28 (1.09–1.51) 1.14 (0.97–1.34) 1.16 (0.97–1.40)
Facility-level readiness�
Have insulin (per SD) 1.26 (0.91–1.74) 1.29 (0.97–1.70) 1.23 (0.98–1.53)
Have metformin (per SD) 1.34 (0.98–1.84) 1.35 (1.01–1.81) 1.27 (0.97–1.66)
Have glibenclamide (per SD) 1.07 (0.78–1.47) 1.13 (0.86–1.49) 1.05 (0.81–1.37)
Offer diabetes diagnostic and management
services
0.56 (0.39–0.82) 0.63 (0.42–0.93) 0.84 (0.60–1.19)
Among those who offer diabetes diagnostic and
management services:
Have trained staff in diabetes diagnostic and
management (per SD)
0.83 (0.62–1.12) 0.88 (0.73–1.06) 0.90 (0.82–0.99)
Have guidelines for diagnosis and
management (per SD)
0.75 (0.63–0.89) 0.81 (0.71–0.93) 0.90 (0.77–1.05)
Have blood pressure apparatus (per SD) 0.92 (0.56–1.52) 0.87 (0.58–1.30) 0.79 (0.66–0.94)
Have blood glucose measurement capacity
(per SD)
0.95 (0.61–1.48) 1.01 (0.70–1.46) 1.01 (0.77–1.32)
Have adult weighing scale (per SD) 0.59 (0.40–0.86) 0.66 (0.44–1.00) 0.89 (0.64–1.24)
Values are OR (95% CI), adjusted for individual-level age, sex, and education and taking into account sample
weights, which were rescaled by the survey’s sample size such that all countries contributed equally to the overall
estimates.
Abbreviations: CVD, cardiovascular diseases; GDP, gross domestic product; NCD, noncommunicable disease; NRM,
neonatal mortality rate; OR, odds ratio; Ref., reference; SD, standard deviation
https://doi.org/10.1371/journal.pmed.1003268.t006
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cascade steps for hypertension. Interestingly, however, there was no significant association
between GDP or HDI and achieving cascade steps for diabetes care.
Average current health expenditure across included countries was 6.0% of GDP (range:
2.3%–10.5%). Current health expenditure (percentage of GDP) was chosen to reflect the total
amount spent on health (from government [domestic government revenue], OOP expendi-
ture, insurance, and development assistance), as we were interested in overall funding for
health; examining care outcomes by source of funding for health was not part of this analysis.
Chatham House [30] recommends that domestic government expenditure on health alone
should amount to 5% of GDP. That our metric of total expenditure on health was only margin-
ally above this target is consistent with low overall expenditures on health in the countries
included in this study. On average, health service finance markers reflected a lack of equity of
health services in the countries studied; i.e., OOP spending and private health expenditure
were high. To put this in context, in countries where health service access is considered to be
reasonably equitable, for example, Germany and the United Kingdom, OOP expenditure and
private health expenditure as percentage of current is much lower than in our included coun-
tries. In 2016, Germany’s private health expenditure as percentage of current was 15.33 and
the UK’s was 19.76; OOP expenditure in these countries as percentage of current was 12.41
and 15.12, respectively [31]. Nonetheless, in our study, none of the indicators of health financ-
ing were associated with performance for hypertension or diabetes. It might be expected that
necessity to pay for health services, reflected in increasing OOP expenditure on health or pri-
vate healthcare, would limit access to care and thus be associated with worse care-cascade per-
formance. That this expected negative association was not seen might be because it is those
who are wealthier who suffer from CVDRF and they can perhaps also afford to pay for their
management [11–13]. However, this hypothesis requires further study, especially considering
that even the relatively wealthy in many LMICs cannot afford to pay for treatment.
Interestingly, health service performance or readiness indicators—NMR, numbers of physi-
cians, numbers of nurses and midwives—showed a reasonably consistent association with
achievement of cascade steps for hypertension, especially being diagnosed and on treatment.
Others have associated number of hospital beds, physicians, or skilled birth attendants with
overall NCD prevalence and estimated that mortality from NCDs is likely to be largest in
countries that are least prepared in these—and other readiness—domains [14]. Our results are
thus in alignment with these previous findings, although in our study, the association between
number of hospital beds and outcomes was less strong than with other health service indica-
tors. This may be reflective of the outpatient-centred delivery of hypertension care. It is possi-
ble that these measures are better associated with clinical care outcomes, as they are more
proximate to patient care delivery than the NCD readiness indicators; however, that associa-
tions were not consistent suggests that further work needs to be done on the utility of these
indicators before accepting them as truly reflective of health service functioning. Physicians
per 1,000 population (which was a significant predictor of being diagnosed for both hyperten-
sion and diabetes) may be the most promising health service metric for further investigation.
Most countries that responded to the NCD readiness surveys reported that they had an
operational NCD unit/branch or department within the Ministry of Health or equivalent, or
had at least one operational multisectoral national policy, strategy, or action plan that inte-
grates several NCDs and shared risk factors. However, only half of the countries had any fund-
ing for surveillance, prevention, or treatment. Thus, it is perhaps not surprising that there was
no association between achieving cascade steps for either hypertension or diabetes and having
an operational NCD unit or operational policies, if there was no funding to actualise the policy
or the plans of the unit. For hypertension, there were some other expected and positive associ-
ations between NCD readiness indicators and effective clinical care outcomes; however,
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relationships that did exist were weak and not consistent across indicators or cascade steps.
Individuals with hypertension living in countries with evidence-based national guidelines/pro-
tocols/standards for the management of major NCDs through a primary care approach were
significantly more likely to have been diagnosed, but not treated or controlled, suggesting that
guidelines are not enough for transit through the whole care cascade and more investment is
needed in other elements of the health services to ensure that those who are recognised with
disease have guideline-based care to ensure treatment and control. Indeed, in the exploratory
analysis for diabetes, facility availability of medications—which requires most of the WHO
health service building blocks to be in place—was positively associated with care-cascade out-
comes, although this association was not statistically significant.
A number of countries were sent the NCD readiness questionnaire to complete but did not
respond to the request. Interestingly, there seemed to be a positive association between not
returning the survey (‘no response to the survey’) and some care-cascade outcomes, especially
for diabetes. The reasons behind this finding require further exploration. Additionally, for dia-
betes, there were a number of other health service indicators for which apparent success in
achievement was associated with worse-quality clinical care outcomes. This study was not
planned to explore causation or the reasons for these negative associations—our plan was to
see if any positive associations existed. Further exploration of these findings goes beyond this
study’s remit.
This study has several limitations. The survey data that we used to complete the care cas-
cades are epidemiology studies, which rely on field data rather than formal clinical diagnoses
of hypertension or diabetes. Formal clinical diagnoses require more detailed investigation. For
example, at least two elevated BP recordings on separate, consecutive occasions are required to
meet a diagnosis of hypertension, and definitive diagnosis of diabetes requires oral glucose tol-
erance testing. In large-scale epidemiology surveys, these methods are not feasible, and
although the survey’s results are accepted in the literature as reliable estimates, we recognise
that these may be over- or underestimates [11–13,16,32]. We also used self-report of individu-
als’ diagnoses or treatment; unfortunately, healthcare records in most LMICs included in this
analysis are not well maintained or reliable; thus, self-report is currently the best available
method of capturing these variables. Data were not available for care cascades and health ser-
vice indicators for all LMICs, and for some analyses, sample sizes were small. That said, our
country sample size was larger than others who have looked at similar associations between
health services and outcomes in the field of maternal health—and with whom our findings are
similar. Changes in the NCD readiness indicators [8] over time and the inconsistent availabil-
ity of survey results within 2 years of collection of care-cascade data meant that not all coun-
tries in our study had data. Nevertheless, data were available for many of the questions for
most countries. We aggregated funding availability into a single metric, in order to simplify
the interpretation, and have not found associations between a specific funding stream and
improved outcomes at care-cascade steps; assessing whether targeted funding associates with
improved outcomes requires further investigation. We used data from both SARA and SPA
for the exploratory analysis of health facility readiness and cascade outcomes. We preferred
SARA over SPA, as more countries had SARA data available; we only used SPA data for one
country. We acknowledge that the data may not be completely comparable from these two sur-
vey methodologies; however, the questions that we used in our comparisons were very similar.
Additionally, SARA and SPA surveys do not capture information from retail pharmacies or
other places of care delivery outside of the formal sector; these providers are often used by
patients with CVDRFs, but unfortunately, our data on medications availability did not cover
them. Our aggregation of individual-patient clinical outcomes and SARA or SPA data at a
national level may mask some positive associations between these variables which may be seen
PLOS MEDICINE Association between preparedness indicators and provision of care for CVD risk factors LMICs
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003268 November 10, 2020 20 / 25
if these were available to be analysed at a local level, but data were not available for that level of
study. We only included countries who had data on indicators within 2 years of the care-cas-
cade data being collected. This was done to ensure data were contemporaneous; however, we
cannot exclude temporal confounding. Our analyses did not allow estimations of causation,
and we cannot account for the effects of nonmeasured confounders on these results. Although
we have found that health service indicators do not add predictive value to achieving care-cas-
cade steps above individual participant–level factors, it may be that countries who had
achieved all indicators, a larger number of indicators, or a certain combination of indicators
better achieved care-cascade steps than others. Lastly, we have only assessed one of the require-
ments for quality care (i.e., that it is effective); our data do not allow us to assess whether it is
also safe, timely, efficient, equitable, and people-centred [33].
The implications for policy are that the totality of evidence suggests that although com-
monly used health service assessment tools contain some of the elements required to achieve
quality clinical care, positive responses to these elements may not actually reflect quality clini-
cal care. In other words, although elements that are indicative of health service preparedness
or readiness, and policies to enable these, are necessary for delivery of quality clinical care,
they are not sufficient for its delivery. Given that collection and compilation of the totality of
these indicators requires substantial human effort [2,3], it may be more efficient to directly
capture patient care outcomes and individual person factors, like sex, age, and education, as
the most reliable way of judging progress towards achieving equitable, quality clinical care
[34]. Similar individual measures of quality clinical care have been the driving force behind
reducing maternal and neonatal mortality and the burden of HIV [35, 36]. Although access to
good antenatal care or availability of antiretrovirals is an important step to achieving these end
points, the human-outcome end point (e.g., the UNAIDS 90-90-90 target for persons with
HIV [35]) is unquestionably the most important to assess. To ensure the UN High-Level Com-
mission and SDG targets for NCDs are met [1,37], it is likely that similar targets need to be put
in place for CVDRFs. Proxy health service markers can then be used to define where barriers
to care are in countries that do not meet quality clinical care targets—perhaps defined as those
that are achievable in other settings with well-functioning health services [32]. Nevertheless, it
should be noted that some of the indicators used in this study are also collected for other mon-
itoring purposes, and although we have shown their lack of utility as a proxy for quality clinical
care outcomes for CVDRFs, they may have utility for these other purposes. That utility should
be tested in further studies.
In summary, country preparedness indicators to deliver CVDRF care have been collected
for a number of years, and although questions have been refined over time, their focus has
remained the same—they are reflective of components thought necessary to produce an
improvement in NCD management in countries. Like facility-assessment surveys, these
require investments of human capital and resources to complete. Our findings suggest that
these surveys do not reflect quality clinical care outcomes for diabetes or hypertension.
Although building blocks for health services and services reflected by these indicators are
needed to provide care, to monitor if good clinical outcomes are achieved, individual-level out-
comes data are needed.
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Mohamed Msaidié, Glennis Andall-Brereton, Garry Brian, Andrew Stokes, Sebastian Voll-
mer, Till Bärnighausen, Rifat Atun, Pascal Geldsetzer, Jennifer Manne-Goehler, Lindsay M.
Jaacks.
References
1. UN. Sustainable Development Goals. Available from: https://sustainabledevelopment.un.org/?menu=
1300. [cited 2019 Aug 29]
2. Kruk ME, Gage AD, Arsenault C, Jordan K, Leslie HH, Roder-DeWan S, et al. High-quality health sys-
tems in the Sustainable Development Goals era: time for a revolution. Lancet Global Health. 2018; 6
(11):E1196–E252. https://doi.org/10.1016/S2214-109X(18)30386-3 PubMed PMID:
WOS:000447187900015. PMID: 30196093
3. Health Data Collaborative. Health data collaborative progress report 2016–2017. 2017 [cited 2019
Aug]. Available from: https://www.uhc2030.org/news-events/uhc2030-news/health-data-collaborative-
progress-report-2016-2017-406570/.
4. WHO. Global Reference List of 100 Core Health Indicators (plus health-related SDGs). Geneva:
WHO; 2018.
5. PHCPI. The PHCPI Conceptual Framework. 2020 [cited 2020 Mar]. Available from: https://
improvingphc.org/phcpi-conceptual-framework.
6. Holmer H, Bekele A, Hagander L, Harrison EM, Kamali P, Ng-Kamstra JS, et al. Evaluating the collec-
tion, comparability and findings of six global surgery indicators. Br J Surg. 2019; 106(2):e138–e50.
Epub 2018/12/21. https://doi.org/10.1002/bjs.11061 PMID: 30570764.
7. Donabedian A. The Quality of Care: How Can It Be Assessed? JAMA. 1988; 260(12):5. https://doi.org/
10.1001/jama.1988.03410120089033
8. WHO. National capacity to address and respond to NCDs: Existence of operational policies, strategies,
or action plans. 2016 [cited 2017 Jan 8]. Available from: http://www.who.int/gho/ncd/health_system_
response/policy_text/en/.
PLOS MEDICINE Association between preparedness indicators and provision of care for CVD risk factors LMICs
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003268 November 10, 2020 23 / 25
9. WHO. Service Availability and Readiness Assessments Geneva. 2019 [cited 2019 Aug 16]. Available
from: https://www.who.int/healthinfo/systems/sara_related_links/en/.
10. DHS. Service Provision Assessments. DHS; 2019 [cited 2019 Aug 16]. Available from: https://
dhsprogram.com/What-We-Do/Survey-Types/SPA.cfm.
11. Geldsetzer P, Manne-Goehler J, Marcus M-E, Ebert C, Zhumadilov Z, Wesseh CS, et al. The state of
hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally
representative individual-level data from 1.1 million adults. The Lancet. 2019; 394(10199):652–662.
https://doi.org/10.1016/S0140-6736(19)30955-9
12. Manne-Goehler J, Geldsetzer P, Agoudavi K, Andall-Brereton G, Aryal KK, Bicaba BW, et al. Health
system performance for people with diabetes in 28 low- and middle-income countries: A cross-sectional
study of nationally representative surveys. PLoS Med. 2019; 16(3):e1002751. https://doi.org/10.1371/
journal.pmed.1002751 PMID: 30822339
13. Geldsetzer P, Manne-Goehler J, Theilmann M, Davies JI, Awasthi A, Vollmer S, et al. Diabetes and
Hypertension in India A Nationally Representative Study of 1.3 Million Adults. JAMA Internal Medicine.
2018; 178(3):363–72. https://doi.org/10.1001/jamainternmed.2017.8094 PubMed PMID:
WOS:000427030000010. PMID: 29379964
14. Bollyky TJ, Templin T, Cohen M, Dieleman JL. Lower-Income Countries That Face The Most Rapid
Shift In Noncommunicable Disease Burden Are Also The Least Prepared. Health Aff (Millwood). 2017;
36(11):1866–75. Epub 2017/11/16. https://doi.org/10.1377/hlthaff.2017.0708 PMID: 29137514.
15. Collaborative GBD. Global, regional, and national disability-adjusted life-years (DALYs) for 315 dis-
eases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global
Burden of Disease Study 2015. Lancet. 2016; 388(10053):1603–58. Epub 2016/10/14. https://doi.org/
10.1016/S0140-6736(16)31460-X PMID: 27733283.
16. Manne-Goehler J, Atun R, Stokes A, Goehler A, Houinato D, Houehanou C, et al. Diabetes diagnosis
and care in sub-Saharan Africa: pooled analysis of individual data from 12 countries. The Lancet Diabe-
tes & Endocrinology. 2016; 4(11):903–12. https://doi.org/10.1016/s2213-8587(16)30181-4
17. Riley L, Guthold R, Cowan M, Savin S, Bhatti L, Armstrong T, et al. The World Health Organization
STEPwise Approach to Noncommunicable Disease Risk-Factor Surveillance: Methods, Challenges,
and Opportunities. American Journal of Public Health. 2016; 106(1):74–8. https://doi.org/10.2105/
AJPH.2015.302962 PMID: 26696288
18. WHO. The STEPS Instrument and Support Materials Geneva. 2015 [cited 2015 Dec 11]. Available
from: http://www.who.int/chp/steps/instrument/en/.
19. Atun R, Aydin S, Chakraborty S, Sumer S, Aran M, Gurol I, et al. Universal health coverage in Turkey:
enhancement of equity. Lancet. 2013; 382(9886):65–99. Epub 2013/07/03. https://doi.org/10.1016/
S0140-6736(13)61051-X PMID: 23810020.
20. Anand S, Barnighausen T. Human resources and health outcomes: cross-country econometric study.
Lancet. 2004; 364(9445):1603–9. Epub 2004/11/03. https://doi.org/10.1016/S0140-6736(04)17313-3
PMID: 15519630.
21. UN. Human Development Reports. 2019 [cited 2019 Mar]. Available from: http://hdr.undp.org/en/
composite/trends.
22. World Bank. World Development Indicators 2016. World Bank; 2016 Apr 27.
23. Atun R. Health systems, systems thinking and innovation. Health Policy and Planning. 2012; 27(suppl
4):iv4–iv8. https://doi.org/10.1093/heapol/czs088 PMID: 23014152
24. Atun R, Aydin S, Aran M, Gurol I, Chakraborty S, Akdag R. Health-care reform in Turkey: far from per-
fect—Authors’ reply. Lancet. 2014; 383(9911):e1. Epub 2014/01/07. https://doi.org/10.1016/S0140-
6736(13)62738-5 PMID: 24388314.
25. Atun R, Jaffar S, Nishtar S, Knaul FM, Barreto ML, Nyirenda M, et al. Improving responsiveness of
health systems to non-communicable diseases. The Lancet. 2013; 381(9867):690–7. https://doi.org/10.
1016/s0140-6736(13)60063-x
26. Witter S, Palmer N, Balabanova D, Mounier-Jack S, Martineau T, Klicpera A, et al. Health system
strengthening—Reflections on its meaning, assessment, and our state of knowledge. Int J Health Plann
Manage. 2019; 34(4):e1980–e1980. https://doi.org/10.1002/hpm.2882 PMID: 31386232
27. Atun R, Davies JI, Gale EAM, Bärnighausen T, Beran D, Kengne AP, et al. Diabetes in sub-Saharan
Africa: from clinical care to health policy. The Lancet Diabetes & Endocrinology. 2017; 5(8):622–67.
https://doi.org/10.1016/S2213-8587(17)30181-X
28. Leslie HH, Sun ZY, Kruk ME. Association between infrastructure and observed quality of care in 4
healthcare services: A cross-sectional study of 4,300 facilities in 8 countries. PLoS Med. 2017; 14(12).
https://doi.org/10.1371/journal.pmed.1002464 PubMed PMID: WOS:000418946400002. PMID:
29232377
PLOS MEDICINE Association between preparedness indicators and provision of care for CVD risk factors LMICs
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003268 November 10, 2020 24 / 25
29. Smith JP. Healthy bodies and thick wallets: the dual relation between health and economic status. J
Econ Perspect. 1999; 13(2):144–66. Epub 2004/06/08. PMID: 15179962; PubMed Central PMCID:
PMC3697076.
30. Meheus DMF. Fiscal Space for Domestic Funding of Health and Other Social Services. London, UK:
Chatham House; 2014.
31. World Bank. World Development Indicators 2019. Available from: http://data.worldbank.org. [cited 2019
Aug]
32. Basu S, Wagner RG, Sewpaul R, Reddy P, Davies J. Implications of scaling up cardiovascular disease
treatment in South Africa: a microsimulation and cost-effectiveness analysis. The Lancet Global health.
2019; 7(2):e270–e80. Epub 2018/12/12. https://doi.org/10.1016/S2214-109X(18)30450-9 PMID:
30528531.
33. WHO. Standards for improving quality of maternal and newborn care in health facilities. Geneva:
WHO; 2016.
34. Palafox B, McKee M, Balabanova D, AlHabib KF, Avezum AJ, Bahonar A, et al. Wealth and cardiovas-
cular health: a cross-sectional study of wealth-related inequalities in the awareness, treatment and con-
trol of hypertension in high-, middle- and low-income countries. Int J Equity Health. 2016; 15(1):199.
Epub 2016/12/10. https://doi.org/10.1186/s12939-016-0478-6 PMID: 27931255; PubMed Central
PMCID: PMC5146857.
35. UNAIDS. 90:90:90 An ambitious treatment target to help end the AIDS epidemic. 2014.
36. Celum C, Barnabas R. Reaching the 90-90-90 target: lessons from HIV self-testing. The Lancet HIV.
2019; 6(2):E68–E9. https://doi.org/10.1016/S2352-3018(18)30289-3 PubMed PMID:
WOS:000457727600002. PMID: 30584046
37. WHO. WHO Independent High-level Commission on NCDs. Geneva: WHO; 2018 [cited 2019 Aug 29].
Available from: https://www.who.int/ncds/governance/high-level-commission/en/.
PLOS MEDICINE Association between preparedness indicators and provision of care for CVD risk factors LMICs
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003268 November 10, 2020 25 / 25
